Sign Out
Pregnancy: There are no or limited amount of data from the use of Duspatalin in pregnant women.
Animal studies are insufficient with respect to reproductive toxicity (see Pharmacology: Toxicology: Preclinical Safety Data under Actions). Duspatalin is not recommended during pregnancy.
Lactation: It is unknown whether mebeverine or its metabolites are excreted in human milk. The excretion of mebeverine in milk has not been studied in animals. Duspatalin should not be used during breast-feeding.
Fertility: There are no clinical data regarding impact on male or female fertility; however, available animal studies do not indicate harmful effects of trademark (see Pharmacology: Toxicology: Preclinical Safety Data under Actions).
